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Abstract  Eosinophilic  esophagitis  is  an  inﬂammatory  condition  in  which  there  is  dense
eosinophilic  inﬁltration  of  the  esophageal  lining  epithelium.  The  adult  form  has  only  recently
gained recognition  as  a  distinct  entity.  Because  of  the  reﬂux-type  symptomatology,  it  is
commonly misdiagnosed  and  treated  as  severe  gastroesophageal  reﬂux  disease  before  an  appro-
priate diagnosis  is  made.  We  herein  present  a  case  of  an  asthmatic  young  woman  in  whom
eosinophilic  esophagitis  was  suspected  based  on  symptoms  of  gastroesophageal  reﬂux  dis-
ease refractory  to  standard  medical  therapy.  Biopsies  taken  from  esophageal  normal  appearing
mucosa were  essential  to  establish  the  diagnosis.  She  was  successfully  treated  with  swallowed
ﬂuticasone.
As clinical  and  pathologic  features  of  gastroesophageal  reﬂux  disease  and  eosinophilic
esophagitis  may  overlap,  proper  diagnosis  requires  a  keen  index  of  suspicion.  Increased  aware-
ness of  eosinophilic  esophagitis  is  necessary,  since  treatment  with  topical  steroids  may  be  more
effective than  acid  suppression.
©  2010  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
PALAVRAS-CHAVE
Eosinóﬁlos;
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Doenc¸a  do  reﬂuxo
gastroesofágico;
Esofagite  eosinofílica  e  azia  refratária:  relato  de  caso  e  revisão  da  literatura
Resumo  A  esofagite  eosinofílica  constitui  uma  condic¸ão  inﬂamatória  em  que  ocorre  exu-
berante inﬁltrac¸ão  do  epitélio  esofágico  por  eosinóﬁlos.  No  adulto,  apenas  recentemente  foi
reconhecida  como  uma  entidade  distinta.  Devido  à  semelhanc¸a  clínica,  é  muitas  vezes  confun-Asma; dida e  tratada  como  a  doenc¸a  do  reﬂuxo  gastroesofágico  severa  antes  do  estabelecimento  do
Fluticasona diagnóstico  correto.  Apresenta-se  o  caso  de  uma  doente  jovem  com  asma  em  quem  a  esofagite
eosinofílica  foi  suspeitada  perante  sintomas  de  reﬂuxo  gastroesofágico  refratários  à  terapêutica
médica standard.  A  obtenc¸ão  de  biopsias  da  mucosa  esofágica  com  aspeto  endoscopicamente
normal  foi  essencial  para  o  estabelecimento  do  diagnóstico.  A  doente  foi  tratada  com  sucesso
com ﬂuticasona  deglutida.
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Como  as  características  clínicas  e  anatomo-patológicas  da  doenc¸a  do  reﬂuxo  gastroesofágico
e da  esofagite  eosinofílica  poderão  sobrepor-se,  o  diagnóstico  requer  um  elevado  grau  de
suspeita.  Torna-se  assim  necessária  a  crescente  sensibilizac¸ão  para  esta  entidade,  já  que  a
corticoterapia  tópica  poderá  ser  mais  eﬁcaz  do  que  a  supressão  ácida.
© 2010  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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The  patient  was  treated  with  a  ﬂuticasone  inhaler  (four
200  g  puffs  twice  daily),  with  instructions  to  swallow  and  to
rinse  her  mouth.  She  also  continued  treatment  with  pump-
inhibitor  (omeprazol  40  mg/day).ntroduction
osinophilic  esophagitis  is  an  increasingly  recognized  cause
f  atypical  chest  pain  and  heartburn  that  does  not  respond
o  aggressive  anti-reﬂux  therapy.  It  is  best  known  in  the  pedi-
tric  population,  but  its  recognition  in  adults  has  increased
ver  the  past  10  years.
The  cause  of  eosinophilic  esophagitis  is  poorly  under-
tood,  but  allergic  and  immune-mediated  mechanisms
imilar  to  those  of  asthma  are  implicated.1
Eosinophilic  esophagitis  is  deﬁned  as  a  clinicopathologic
ntity,  combining  clinical  data  on  (1)  relevant  symp-
oms  (distinct  in  the  pediatric  or  adult  populations,  with
ostly  food  impaction  and  dysphagia  in  adults  and  feed-
ng  intolerance,  failure  to  thrive  and  gastroesophageal
eﬂux  disease  (GERD)  symptoms  in  children  and  adolescent);
2)  esophageal  biopsies  with  adequate  histologic  ﬁndings
≥20  eosinophils/  high-power  ﬁeld);  and  (3)  exclusion  of
ther  diseases  with  overlapping  features,  especially  GERD.1
Endoscopic  examination  of  the  esophagus  may  reveal  fur-
ows,  corrugations,  rings,  whitish  plaques,  crêpe-paper  like
ppearance  and  a  small-caliber  esophagus.  Demonstration
f  marked  eosinophilic  inﬁltration  in  the  esophageal  epithe-
ia  is  the  diagnostic  hallmark  and  biopsies  should  be  taken
ven  in  normal-appearing  mucosa  if  clinical  suspicion  is  high.
Optimal  treatment  remains  unclear.2 Swallowed  ﬂuti-
asone,  proton  pump  inhibitor  and  avoidance  of  dietary
nd  airborne  allergens  may  be  helpful  in  some  patients.
vailable  data  suggests  that  eosinophilic  esophagitis  runs
 benign  course,  albeit  with  relapses  and  need  of  re-
reatment.
We  herein  present  a  case  of  eosinophilic  esophagitis  in
oung  woman  with  asthma  and  symptoms  of  GERD  refractory
o  maximal  doses  of  pump  inhibitor.  Awareness  and  a  high
ndex  of  suspicion  were  essential  to  establish  the  diagnosis.
linical  symptoms  and  esophageal  histology  improved  with
wallowed  ﬂuticasone.
ase report
 22-year-old  woman  with  a  history  of  asthma  since  child-
ood  presented  with  heartburn.  Complaints  were  worse  in
ecumbent  position  and  after  meals.  There  was  no  history
f  vomiting,  dysphagia,  food  impaction  or  hematemesis.  She
ad  no  constitutional  features  such  as  weight  loss,  fever  or
ny  other  symptom  suggesting  systemic  disease.
Physical  examination  was  unremarkable  and  complete
lood  counts  revealed  discrete  eosinophilia,  with  an
F
aosinophilic  count  of  680/L (10%)  (upper  limit  of  normal  =
00/L  (6%)).  There  was  no  anemia,  IgE  levels  were  normal
nd  speciﬁc  IgE  to  pollens  and  grass  was  positive.
An  upper  gastrointestinal  endoscopy  was  performed  and
evealed  a  normal  appearing  mucosa  (Fig.  1).  No  biopsies
ere  taken  and  she  was  diagnosed  with  non-erosive  reﬂux
isease.  A  3  month  trial  with  proton  pump  inhibitors  at
aximal  doses  was  tried,  but  heartburn  persisted  and  she
egan  to  complaining  of  intermittent  solid-food  dysphagia.
sophageal  motility  study  with  pH  monitoring  and  barium
adiography  (Fig.  2)  were  performed  and  found  to  be  normal.
Because  of  persistent  heartburn  that  did  not  improve
ith  appropriate  medical  treatment  and  taking  in  to
ccount  her  past  asthmatic  history,  eosinophilic  esophagi-
is  was  suspected.  Upper  gastrointestinal  endoscopy  was
hen  repeated  and  again  revealed  normal-appearing  mucosa
f  esophagus,  stomach  and  duodenum.  Notwithstanding,
iopsies  were  obtained  from  the  proximal  and  distal  esoph-
gus.  Histological  examination  revealed  more  than  20
ntraepithelial  eosinophils  per  high  power  ﬁeld  and  multi-
le  eosinophilic  microabcesses  (Fig.  3),  both  diagnostic  of
osinophilic  esophagitis.  Biopsies  from  stomach  and  duo-
enum  were  also  obtained  and  histological  ﬁndings  were
ormal.igure  1  Upper  gastrointestinal  endoscopy  with  normal
ppearing  mucosa.
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GFigure  2  Barium  esophagography  was  unremarkable.
During  the  next  6  months,  her  symptoms  improved.  An
endoscopy  was  then  carried  out  and  new  biopsies  from  mid-
dle  and  distal  esophagus  were  taken.  No  eosinophils  were
found  in  the  biopsy  specimen.
Discussion
Increased  number  of  eosinophils  in  the  gastrointestinal
tract  has  been  described  in  a  variety  of  diseases  includ-
ing  Crohn’s  disease,  connective  tissue  disorders,  malignancy
and  hypersensivity  reactions.1 However,  not  until  1993  was
eosinophilic  esophagitis  described  as  a  clinical  entity.3The  pathologic  mechanisms  of  eosinophilic  esophagitis
are  unknown,  but  emerging  evidence  suggests  that,  like
many  other  allergic  diseases,  it  is  mediated  by  a  type  2  T
helper  cell  immune  response.  Actually,  up  to  80%  of  patients
Figure  3  Histological  examination  with  more  than  20
intraepithelial  eosinophils  per  high  power  ﬁeld  and  multiple
eosinophilic  microabcesses.
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end  review  of  literature  261
ith  eosinophilic  esophagitis  have  a  history  of  atopic  dis-
ase  such  as  asthma,  allergic  rhinitis,  eczema  or  allergies  to
ood.1 Peripheral  eosinophilia  is  seen  in  31%  of  patients.4 Our
atient  showed  increased  blood  eosinophils  but  the  serum
gE  level  was  normal  and  she  had  a  history  of  bronchial
sthma.
Clinical  presentations  of  this  newly  recognized  disease
nclude  dysphagia  (93%),  food  impaction  (62%),  atypical
hest  pain  and  heartburn  (34%)4 that  does  not  respond  to
tandard  medical  treatment.
Careful  endoscopic  examination  may  reveal  ringed
ppearance,  subtle  furrows,  whitish  plaques,  fragile  crêpe
aper-like  appearance  and  a  small-caliber  esophagus.
etween  9%  and  32%  of  patients  with  symptoms  have  normal
ndoscopic  ﬁndings.1
Barium  radiography  may  demonstrate  concentric  rings
r  strictures  and  should  be  performed  before  esophageal
ilatation.  Esophageal  manometry  is  of  limited  diagnostic
alue  and  so  is  not  recommended  as  a  routine  test.1
Marked  eosinophil  inﬁltration  in  the  esophageal  epithelia
>20  eosinophils  per  high-power  ﬁeld)  is  the  diagnostic  hall-
ark  and  samples  should  be  obtained  from  proximal  and
istal  esophagus,1--4 even  in  normal  appearing  mucosa  in
ndoscopy.5 In  our  case  report,  we  found  normal  appear-
ng  mucosa  at  endoscopy,  but  esophageal  biopsies  revealed
arked  eosinophilic  inﬁltration.  Recently,  a prospective
tudy  conducted  by  Prasad  G.  et  al.  concluded  that  mides-
phageal  biopsies  taken  from  normal-appearing  mucosa  in
atients  with  unexplained  solid  food  dysphagia  may  diagnose
osinophilic  esophagitis  in  about  one  in  10  cases.6
Clinical  and  pathologic  features  of  gastroesophageal
eﬂux  disease  (GERD)  and  eosinophilic  esophagitis  may
verlap.5 Both  diseases  share  varying  degrees  of  esophageal
osinophilia  and  some  authors  suggest  that  mucosal  injury
aused  by  acid  reﬂux  may  allow  swallowed  allergens  to
enetrate  esophageal  mucosa  causing  mild  eosinophilia.5,7
astroesophageal  reﬂux  disease  is  actually  the  most  com-
on  cause  of  eosinophilic  inﬁltration  of  the  esophagus.
owever,  GERD-related  inﬁltrates  tend  to  be  less  dense
nd  the  greatest  number  is  in  the  distal  esophagus,  whereas
he  dense  inﬁltrates  of  eosinophilic  esophagitis  are  seen
hroughout  the  esophagus.5,7 Because  of  this  possible  over-
ap,  the  diagnosis  of  eosinophilic  esophagitis  should  be  made
fter  acid  reﬂux  has  been  treated  or  excluded.1,5 Before  we
onsidered  eosinophilic  esophagitis  diagnosis  and  performed
sophageal  biopsies,  our  patient  tried  a  trial  with  pump
roton  inhibitor  at  maximum  doses  and  a pH  monitoring
xcluded  pathologic  gastroesophageal  reﬂux.  Therefore,
ur  patient  met  all  criteria  for  deﬁnitive  diagnosis  of
osinophilic  esophagitis:  clinical  symptoms,  compatible  his-
ology  and  lack  of  responsiveness  to  high-dose  pump  proton
nhibitor  with  normal  pH  monitoring  of  the  distal  esophagus.
Because  many  patients  with  eosinophilic  esophagitis
ave  atopic  disease,  a  complete  evaluation  for  dietary
nd  inhaled  allergens  by  an  experienced  allergist  is  rec-
mmended.  Although  we  could  not  ﬁnd  any  correlation
etween  our  patient’s  reﬂux  symptoms  and  exposition  to
ollens  or  grass,  avoidance  of  allergens  may  be  helpful  in
ome  patients.1 Large-scale  studies  in  adults  have  not  been
onducted.
There  is  no  consensus  regarding  the  treatment  of
osinophilic  esophagitis.  In  adults,  food  allergy  is  less
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esponsible  and  treatment  with  topical  steroids  has
ead  to  remission  of  symptoms  and  normalization  of
itopathology.1,8 Treatment  involves  spraying  and  actuation
f  ﬂuticasone  from  an  inhaler  into  the  mouth  and  having
he  patient  swallow.  Patients  should  be  instructed  to  avoid
ood  and  liquids  for  at  least  30  minutes  after  use.1,9 A  trial
f  a  proton  pump  inhibitor  at  maximum  doses  for  at  least
 weeks  is  also  recommended.1 Swallowed  ﬂuticasone  was
ery  effective  in  our  patient,  leading  to  complete  clinical
emission  after  one  month  of  treatment.  After  six  months
f  treatment,  there  were  no  eosinophils  in  esophageal  biop-
ies.
In  patients  whose  symptoms  do  not  improve  with  ﬂu-
icasone,  several  other  medications  may  be  tried  like
ystemic  corticosteroids,  cromolyn  sodium  and  montelukast.
 recent  open-label  trial  with  mepolizumab,  a  human-
zed  monoclonal  antibody  to  human  interleukin  5,  improved
linical  symptoms  in  patients  with  refractory  eosinophilic
sophagitis.10
Esophageal  stenosis  may  complicate  esophageal
sophagitis.  Endoscopic  dilation  with  either  a  guidewire  or
 balloon  technique  may  be  used,  despite  the  increased
isk  of  perforation  compared  with  other  indications  for
ilatation.1
The  long-term  prognosis  of  eosinophilic  esophagitis  is
ncertain,  but  data  suggests  a  benign  course,  despite  the
hronic  and  relapsing  nature  of  this  entity.
onclusion
osinophilic  esophagitis  is  a  recently  recognized  disorder
eceiving  increasing  attention.  Clinicians  should  have  a  high
uspicion  for  this  condition  in  younger  patients  with  atopic
ymptoms  presenting  with  dysphagia,  food  impaction  or
eartburn  that  does  not  respond  to  maximal  doses  of  proton
ump  inhibitor.
Our  case  report  emphasizes  that  in  patients  with  refrac-
ory  GERD  symptoms,  biopsies  taken  from  esophageal
1I.  Marques  et  al.
ormal  appearing-mucosa  may  be  worthwhile.  It  is  imper-
tive  to  consider  eosinophilic  esophagitis  in  the  differential
iagnosis  of  treatment  resistant  GERD,  as  the  dichotomy  of
he  treatment  modalities  may  result  in  early  recovery  of  this
ondition  and  avoid  complications.
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